Article
SIRT1 regulates oncogenesis via a mutant p53-dependent pathway in hepatocellular carcinoma.
Journal of hepatology - 1 Jan 2015
Zhang Zheng Yun, Hong Doopyo, Nam Seung Hoon, Kim Jong Man, Paik Yong Han, Joh Jae Won, Kwon Choon Hyuck David, Park Jae Berm, Choi Gyu-Seong, Jang Kyu Yun, Park Cheol Keun, Kim Sung Joo
Abstract excerpt
BACKGROUND & AIMS: SIRT1 is a class III histone deacetylase that plays diverse roles in various cancers. However, the clinical significance of SIRT1 in hepatocellular carcinoma (HCC) remains unknown. METHODS: We analysed p53 mutations and the activation of SIRT1 in 252 hepatitis B virus-positive HCC cases. None of the patients had been subjected to pre-operative treatment. RESULTS: We examined 57 p53 mutations...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
